The Regulations do not create any legal requirements or make recommendations to services on the clinical governance procedures they should have in place covering the purchase, storage or use of naloxone. However, authoritative guidance recommends that services provide relevant advice and training alongside the arrangements for supply of naloxone. This may include developing suitable local protocols which might summarise who can receive naloxone in what circumstances, product choice, training, storage, monitoring and record keeping.